Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-25-018706
Filing Date
2025-04-22
Accepted
2025-04-22 06:09:10
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2025proxycardnotice.htm DEFA14A 4470
2 a2025proxycardnotice001.jpg GRAPHIC 94761
3 a2025proxycardnotice002.jpg GRAPHIC 159941
4 a2025proxycardnotice003.jpg GRAPHIC 92098
  Complete submission text file 0001628280-25-018706.txt   483243
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41536 | Film No.: 25854884
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)